Addressing the Current State of Novel Viral Platforms in Oncology To Demonstrate Increased Therapeutic Potential
Time: 9:00 am
day: Day One
Details:
- Overview of traditional and novel oncolytic and non-oncolytic viral platforms
- Understanding their advantages and unique characteristics
- Engineering a non-oncolytic immuno-virotherapy based on Lymphocytic Choriomeningitis Virus with enhanced tumour cell targeting
